

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63305468 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.63305468 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28849725 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.28849725 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.97852707 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.37747421 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.37747421 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.37747421 |
| 9 | kynurenine metabolic process (GO:0070189) | 6.26515465 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.20672452 |
| 11 | bile acid biosynthetic process (GO:0006699) | 6.14730941 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.98882984 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.87693195 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.82164242 |
| 15 | urea metabolic process (GO:0019627) | 5.81115808 |
| 16 | urea cycle (GO:0000050) | 5.81115808 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.49674436 |
| 18 | regulation of protein activation cascade (GO:2000257) | 5.47122425 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.45614439 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.36205595 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.36119368 |
| 22 | protein carboxylation (GO:0018214) | 5.36119368 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 5.35354683 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.31875169 |
| 25 | cysteine metabolic process (GO:0006534) | 5.27409383 |
| 26 | bile acid metabolic process (GO:0008206) | 5.18897038 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.17439387 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14505371 |
| 29 | regulation of complement activation (GO:0030449) | 5.09984390 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.08760614 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 5.06745385 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.89378274 |
| 33 | tyrosine metabolic process (GO:0006570) | 4.79331221 |
| 34 | acylglycerol homeostasis (GO:0055090) | 4.73042563 |
| 35 | triglyceride homeostasis (GO:0070328) | 4.73042563 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.69611943 |
| 37 | lysine metabolic process (GO:0006553) | 4.68766021 |
| 38 | lysine catabolic process (GO:0006554) | 4.68766021 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.65192652 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.65182089 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.64409272 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61464123 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.61464123 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.61464123 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.59464984 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.59191187 |
| 47 | coenzyme catabolic process (GO:0009109) | 4.58316332 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 4.51477270 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.50246030 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.50246030 |
| 51 | phospholipid efflux (GO:0033700) | 4.45186036 |
| 52 | glycine metabolic process (GO:0006544) | 4.44321341 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.42695522 |
| 54 | amine catabolic process (GO:0009310) | 4.40260809 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 4.40260809 |
| 56 | cellular glucuronidation (GO:0052695) | 4.32449579 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 4.27050991 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.21723180 |
| 59 | imidazole-containing compound metabolic process (GO:0052803) | 4.20220299 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 4.19250935 |
| 61 | glutamate metabolic process (GO:0006536) | 4.19136221 |
| 62 | cholesterol efflux (GO:0033344) | 4.15192858 |
| 63 | ethanol oxidation (GO:0006069) | 4.14882594 |
| 64 | benzene-containing compound metabolic process (GO:0042537) | 4.11614459 |
| 65 | arginine metabolic process (GO:0006525) | 4.07699396 |
| 66 | cytolysis (GO:0019835) | 4.05660482 |
| 67 | aldehyde catabolic process (GO:0046185) | 4.04816510 |
| 68 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04103059 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 4.02196187 |
| 70 | ketone body metabolic process (GO:1902224) | 3.97508144 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.94688535 |
| 72 | fibrinolysis (GO:0042730) | 3.91271316 |
| 73 | complement activation, classical pathway (GO:0006958) | 3.87131918 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.86203841 |
| 75 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86129113 |
| 76 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86129113 |
| 77 | uronic acid metabolic process (GO:0006063) | 3.85147561 |
| 78 | glucuronate metabolic process (GO:0019585) | 3.85147561 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.81076582 |
| 80 | cofactor catabolic process (GO:0051187) | 3.79552074 |
| 81 | blood coagulation, intrinsic pathway (GO:0007597) | 3.78174330 |
| 82 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76946991 |
| 83 | carboxylic acid catabolic process (GO:0046395) | 3.76804621 |
| 84 | organic acid catabolic process (GO:0016054) | 3.76804621 |
| 85 | acetyl-CoA metabolic process (GO:0006084) | 3.75818545 |
| 86 | complement activation (GO:0006956) | 3.75112880 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.74599760 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 3.71883713 |
| 89 | protein activation cascade (GO:0072376) | 3.71789701 |
| 90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70849788 |
| 91 | cholesterol homeostasis (GO:0042632) | 3.70558396 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.67990070 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.67502178 |
| 94 | sterol homeostasis (GO:0055092) | 3.64419807 |
| 95 | drug catabolic process (GO:0042737) | 3.63956855 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 3.61956913 |
| 97 | monocarboxylic acid catabolic process (GO:0072329) | 3.52210387 |
| 98 | plasma lipoprotein particle organization (GO:0071827) | 3.50804319 |
| 99 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.50461116 |
| 100 | NAD biosynthetic process (GO:0009435) | 3.49314347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37311855 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21883186 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07879125 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47821351 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28140603 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.01334143 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80910263 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.09451629 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.92170951 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04496762 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02825629 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0412754 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94915946 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59906160 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59482366 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48771660 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40789179 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37678462 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34455969 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22626509 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20624686 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17459461 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11022892 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99365455 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98407648 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98316063 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88060034 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85391631 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85139630 |
| 30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82139181 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82046326 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81580444 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79682642 |
| 34 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77967483 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77871948 |
| 36 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75826984 |
| 37 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75490173 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74541004 |
| 39 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74233359 |
| 40 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71673374 |
| 41 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70601873 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68912980 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68265881 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66614162 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66229927 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66229927 |
| 47 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65934211 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64660199 |
| 49 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64079392 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63786738 |
| 51 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60473037 |
| 52 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59606119 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57998682 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57951685 |
| 55 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57089791 |
| 56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55293130 |
| 57 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54188686 |
| 58 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54138997 |
| 59 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53389809 |
| 60 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52314298 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52234547 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.51468786 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51235887 |
| 64 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50979483 |
| 65 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50909197 |
| 66 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50183856 |
| 67 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49514509 |
| 68 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49389704 |
| 69 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48886168 |
| 70 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47845215 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.45965592 |
| 72 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45724727 |
| 73 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45268422 |
| 74 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44891359 |
| 75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44795374 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.44276588 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43816041 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43008043 |
| 79 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42755384 |
| 80 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41816653 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41807450 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41528780 |
| 83 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41414613 |
| 84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40793401 |
| 85 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40084387 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39890591 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38983368 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38556467 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.37323467 |
| 90 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.37256673 |
| 91 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36982519 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.36956713 |
| 93 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36741184 |
| 94 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35973885 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.35759566 |
| 96 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34867006 |
| 97 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34035055 |
| 98 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33731108 |
| 99 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.33699576 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.32412485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.48109005 |
| 2 | MP0005360_urolithiasis | 7.64684912 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.49050122 |
| 4 | MP0005365_abnormal_bile_salt | 6.19699074 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93302961 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.50010696 |
| 7 | MP0003252_abnormal_bile_duct | 3.96424887 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57373840 |
| 9 | MP0009840_abnormal_foam_cell | 3.11919084 |
| 10 | MP0005083_abnormal_biliary_tract | 2.99841120 |
| 11 | MP0005332_abnormal_amino_acid | 2.73952933 |
| 12 | MP0003195_calcinosis | 2.72245231 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.70876335 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.29311683 |
| 15 | MP0000609_abnormal_liver_physiology | 2.15463071 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.09704342 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.04881568 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.99412315 |
| 19 | MP0003868_abnormal_feces_composition | 1.91271146 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.80843223 |
| 21 | MP0009697_abnormal_copulation | 1.70707004 |
| 22 | MP0001764_abnormal_homeostasis | 1.66749159 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55569717 |
| 24 | MP0005451_abnormal_body_composition | 1.53178597 |
| 25 | MP0003011_delayed_dark_adaptation | 1.33311786 |
| 26 | MP0003186_abnormal_redox_activity | 1.21454033 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.20470052 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.20176168 |
| 29 | MP0005647_abnormal_sex_gland | 1.19450094 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.16205380 |
| 31 | MP0000598_abnormal_liver_morphology | 1.15360971 |
| 32 | MP0002254_reproductive_system_inflammat | 1.05559934 |
| 33 | MP0000604_amyloidosis | 1.03381953 |
| 34 | MP0009764_decreased_sensitivity_to | 1.01217202 |
| 35 | MP0009763_increased_sensitivity_to | 0.99721486 |
| 36 | MP0010368_abnormal_lymphatic_system | 0.91125239 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.89224439 |
| 38 | MP0008469_abnormal_protein_level | 0.87485954 |
| 39 | MP0009642_abnormal_blood_homeostasis | 0.85823452 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 0.82886451 |
| 41 | MP0005408_hypopigmentation | 0.82759893 |
| 42 | MP0005376_homeostasis/metabolism_phenot | 0.80595719 |
| 43 | MP0005670_abnormal_white_adipose | 0.79707399 |
| 44 | MP0002876_abnormal_thyroid_physiology | 0.79337225 |
| 45 | MP0002078_abnormal_glucose_homeostasis | 0.77922693 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.76469245 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.74386342 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 0.72514954 |
| 49 | MP0004130_abnormal_muscle_cell | 0.69571503 |
| 50 | MP0005266_abnormal_metabolism | 0.68517090 |
| 51 | MP0005535_abnormal_body_temperature | 0.67581016 |
| 52 | MP0005334_abnormal_fat_pad | 0.67311617 |
| 53 | MP0002971_abnormal_brown_adipose | 0.67127680 |
| 54 | MP0003690_abnormal_glial_cell | 0.64387813 |
| 55 | MP0001661_extended_life_span | 0.62846742 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 0.62776115 |
| 57 | MP0009053_abnormal_anal_canal | 0.59454581 |
| 58 | MP0000639_abnormal_adrenal_gland | 0.57449061 |
| 59 | MP0003329_amyloid_beta_deposits | 0.57017580 |
| 60 | MP0005448_abnormal_energy_balance | 0.54384207 |
| 61 | MP0001756_abnormal_urination | 0.53834779 |
| 62 | MP0004381_abnormal_hair_follicle | 0.50928541 |
| 63 | MP0005464_abnormal_platelet_physiology | 0.48464968 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.47364586 |
| 65 | MP0005395_other_phenotype | 0.46416907 |
| 66 | MP0002928_abnormal_bile_duct | 0.45962000 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 0.44979263 |
| 68 | MP0002822_catalepsy | 0.44655270 |
| 69 | MP0003724_increased_susceptibility_to | 0.43877926 |
| 70 | MP0003638_abnormal_response/metabolism_ | 0.43452132 |
| 71 | MP0008873_increased_physiological_sensi | 0.42559228 |
| 72 | MP0003718_maternal_effect | 0.42011784 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.41871606 |
| 74 | MP0005166_decreased_susceptibility_to | 0.41645760 |
| 75 | MP0008874_decreased_physiological_sensi | 0.41610028 |
| 76 | MP0003953_abnormal_hormone_level | 0.40710298 |
| 77 | MP0005248_abnormal_Harderian_gland | 0.40033405 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.39040056 |
| 79 | MP0003075_altered_response_to | 0.37069705 |
| 80 | MP0009384_cardiac_valve_regurgitation | 0.36702782 |
| 81 | MP0000579_abnormal_nail_morphology | 0.36701470 |
| 82 | MP0003436_decreased_susceptibility_to | 0.35155926 |
| 83 | MP0008872_abnormal_physiological_respon | 0.34656710 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 0.34580483 |
| 85 | MP0002796_impaired_skin_barrier | 0.34175324 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.32631730 |
| 87 | MP0006082_CNS_inflammation | 0.32237262 |
| 88 | MP0009672_abnormal_birth_weight | 0.31855604 |
| 89 | MP0009115_abnormal_fat_cell | 0.30214373 |
| 90 | MP0004883_abnormal_blood_vessel | 0.29433364 |
| 91 | MP0000249_abnormal_blood_vessel | 0.29010906 |
| 92 | MP0002168_other_aberrant_phenotype | 0.28914476 |
| 93 | MP0001853_heart_inflammation | 0.28710980 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.28359540 |
| 95 | MP0000427_abnormal_hair_cycle | 0.27647093 |
| 96 | MP0001243_abnormal_dermal_layer | 0.27519870 |
| 97 | MP0002970_abnormal_white_adipose | 0.27473336 |
| 98 | MP0002060_abnormal_skin_morphology | 0.24995521 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.24331058 |
| 100 | MP0001881_abnormal_mammary_gland | 0.23969058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.38775496 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.36094709 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.34880810 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.66885064 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.53132144 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.50879372 |
| 7 | Xanthomatosis (HP:0000991) | 6.27645876 |
| 8 | Complement deficiency (HP:0004431) | 5.68491887 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.48011046 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.75131516 |
| 11 | Joint hemorrhage (HP:0005261) | 4.69767421 |
| 12 | Hyperammonemia (HP:0001987) | 4.68137682 |
| 13 | Epidermoid cyst (HP:0200040) | 4.53965372 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.50725734 |
| 15 | Hyperglycinemia (HP:0002154) | 4.37649503 |
| 16 | Ketosis (HP:0001946) | 4.36781907 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.33283095 |
| 18 | Fat malabsorption (HP:0002630) | 4.25470730 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22423532 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.22310225 |
| 21 | Abnormality of complement system (HP:0005339) | 4.15295743 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13906427 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.06253524 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.05118168 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.89262686 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.83468219 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.83468219 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82212399 |
| 29 | Hyperglycinuria (HP:0003108) | 3.81426680 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78863538 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74047217 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.51259767 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41682141 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41481983 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.23673933 |
| 36 | Steatorrhea (HP:0002570) | 3.22680212 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.20254075 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.19425141 |
| 39 | Ketoacidosis (HP:0001993) | 3.19089831 |
| 40 | Spontaneous abortion (HP:0005268) | 3.12306176 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.07455835 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04778277 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.00461548 |
| 44 | Myocardial infarction (HP:0001658) | 2.87330390 |
| 45 | Skin nodule (HP:0200036) | 2.80258874 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.79859693 |
| 47 | Metabolic acidosis (HP:0001942) | 2.79719510 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.66061216 |
| 49 | Lethargy (HP:0001254) | 2.63499874 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.60738712 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60738712 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58562234 |
| 53 | Spastic diplegia (HP:0001264) | 2.57973307 |
| 54 | Gout (HP:0001997) | 2.48471327 |
| 55 | Vascular calcification (HP:0004934) | 2.47717665 |
| 56 | Hypoglycemic seizures (HP:0002173) | 2.47411602 |
| 57 | Acanthocytosis (HP:0001927) | 2.45477682 |
| 58 | Cerebral edema (HP:0002181) | 2.43970167 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.42377727 |
| 60 | Cholelithiasis (HP:0001081) | 2.40035748 |
| 61 | Neonatal onset (HP:0003623) | 2.37340163 |
| 62 | Irritability (HP:0000737) | 2.35185156 |
| 63 | Malnutrition (HP:0004395) | 2.34231498 |
| 64 | Cholecystitis (HP:0001082) | 2.33417307 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.33417307 |
| 66 | Mitral stenosis (HP:0001718) | 2.30379533 |
| 67 | Late onset (HP:0003584) | 2.28021068 |
| 68 | Glomerulonephritis (HP:0000099) | 2.24789965 |
| 69 | Sensorimotor neuropathy (HP:0007141) | 2.24510111 |
| 70 | Gingival bleeding (HP:0000225) | 2.23320595 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.21042036 |
| 72 | Amyloidosis (HP:0011034) | 2.20609774 |
| 73 | Pancreatitis (HP:0001733) | 2.16576561 |
| 74 | Esophageal varix (HP:0002040) | 2.13621731 |
| 75 | Opisthotonus (HP:0002179) | 2.12841160 |
| 76 | Brushfield spots (HP:0001088) | 2.10290565 |
| 77 | Enlarged kidneys (HP:0000105) | 2.10191742 |
| 78 | Vomiting (HP:0002013) | 2.08755183 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.07493708 |
| 80 | Menorrhagia (HP:0000132) | 2.06527173 |
| 81 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06136349 |
| 82 | Thrombophlebitis (HP:0004418) | 2.03233707 |
| 83 | Rickets (HP:0002748) | 2.01103436 |
| 84 | Abnormality of the gallbladder (HP:0005264) | 1.98668178 |
| 85 | Poikilocytosis (HP:0004447) | 1.94162305 |
| 86 | Hemorrhage of the eye (HP:0011885) | 1.91501301 |
| 87 | Renal cortical cysts (HP:0000803) | 1.88154998 |
| 88 | Elevated hepatic transaminases (HP:0002910) | 1.84566612 |
| 89 | Abnormality of vitamin metabolism (HP:0100508) | 1.84219299 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 1.83034629 |
| 91 | Abnormal cartilage morphology (HP:0002763) | 1.82771998 |
| 92 | Status epilepticus (HP:0002133) | 1.82657209 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81233870 |
| 94 | Hypophosphatemic rickets (HP:0004912) | 1.80431180 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79987549 |
| 96 | Hyperglycemia (HP:0003074) | 1.76815404 |
| 97 | Glycosuria (HP:0003076) | 1.75835593 |
| 98 | Abnormality of urine glucose concentration (HP:0011016) | 1.75835593 |
| 99 | Hydroxyprolinuria (HP:0003080) | 1.75283066 |
| 100 | Abnormality of proline metabolism (HP:0010907) | 1.75283066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.28361726 |
| 2 | ERN1 | 4.79832564 |
| 3 | FGFR4 | 4.42548596 |
| 4 | SIK1 | 4.13916660 |
| 5 | ERBB4 | 3.15822886 |
| 6 | TAOK3 | 3.15501174 |
| 7 | INSRR | 2.84851429 |
| 8 | MAP2K4 | 2.42147069 |
| 9 | PIK3CG | 2.33018813 |
| 10 | MST1R | 2.26714859 |
| 11 | PKN2 | 2.21904422 |
| 12 | MAPK11 | 1.97717014 |
| 13 | FLT3 | 1.88228679 |
| 14 | TRIB3 | 1.74002264 |
| 15 | LATS1 | 1.63262343 |
| 16 | ABL2 | 1.59869399 |
| 17 | TYK2 | 1.54426317 |
| 18 | NEK9 | 1.52268249 |
| 19 | PTK6 | 1.49632048 |
| 20 | FRK | 1.42304555 |
| 21 | DAPK2 | 1.39327646 |
| 22 | FGFR2 | 1.24466951 |
| 23 | JAK2 | 1.21856678 |
| 24 | KDR | 1.20660130 |
| 25 | MAP3K7 | 1.19237887 |
| 26 | ERBB2 | 1.17427357 |
| 27 | PINK1 | 1.16455913 |
| 28 | PRKAA2 | 1.07923850 |
| 29 | GRK6 | 1.06442321 |
| 30 | MAP3K10 | 1.06415038 |
| 31 | MAPK4 | 1.04293380 |
| 32 | TBK1 | 1.04286579 |
| 33 | MAP3K14 | 1.03193964 |
| 34 | PRKCZ | 0.98989344 |
| 35 | MAP2K3 | 0.98187523 |
| 36 | MAP2K6 | 0.97580926 |
| 37 | JAK1 | 0.97068771 |
| 38 | EPHB1 | 0.87812240 |
| 39 | CDK6 | 0.85698879 |
| 40 | MAP3K3 | 0.85666961 |
| 41 | MET | 0.84440086 |
| 42 | CAMK2G | 0.82945488 |
| 43 | STK38L | 0.80734487 |
| 44 | MAPK12 | 0.78252561 |
| 45 | TIE1 | 0.76170532 |
| 46 | PRKACG | 0.74615451 |
| 47 | MAP3K11 | 0.74134133 |
| 48 | MAPK15 | 0.70088079 |
| 49 | GSK3A | 0.69246332 |
| 50 | MAPK7 | 0.67836367 |
| 51 | EPHA3 | 0.65226157 |
| 52 | DYRK1B | 0.65154612 |
| 53 | IRAK3 | 0.63865691 |
| 54 | PRKAA1 | 0.63283520 |
| 55 | CAMK1D | 0.62007368 |
| 56 | CSK | 0.61566460 |
| 57 | PRKCQ | 0.59624787 |
| 58 | SGK3 | 0.58231410 |
| 59 | PKN1 | 0.58147140 |
| 60 | RIPK1 | 0.57049648 |
| 61 | CSF1R | 0.56469867 |
| 62 | MAP2K2 | 0.56214575 |
| 63 | TAOK2 | 0.55417864 |
| 64 | PDPK1 | 0.52548544 |
| 65 | PTK2 | 0.51673180 |
| 66 | MAP3K5 | 0.49087785 |
| 67 | IKBKE | 0.48829566 |
| 68 | MAP2K1 | 0.48509682 |
| 69 | TGFBR2 | 0.47941579 |
| 70 | GRK1 | 0.47710924 |
| 71 | EPHA4 | 0.47420836 |
| 72 | CSNK1G1 | 0.43351570 |
| 73 | IGF1R | 0.43090480 |
| 74 | SGK2 | 0.41814007 |
| 75 | RET | 0.40075076 |
| 76 | FGFR3 | 0.39917951 |
| 77 | CDK4 | 0.38125856 |
| 78 | PRKCG | 0.37690851 |
| 79 | PBK | 0.36019692 |
| 80 | MAP3K6 | 0.35396985 |
| 81 | EGFR | 0.34538785 |
| 82 | SGK494 | 0.33940941 |
| 83 | SGK223 | 0.33940941 |
| 84 | CAMK4 | 0.33502114 |
| 85 | PDK1 | 0.32744968 |
| 86 | PAK3 | 0.32581131 |
| 87 | MAP3K2 | 0.31958477 |
| 88 | MAP3K13 | 0.31890913 |
| 89 | LATS2 | 0.29092630 |
| 90 | ICK | 0.28956144 |
| 91 | MAP3K1 | 0.28495143 |
| 92 | MTOR | 0.28169189 |
| 93 | PRKCA | 0.27240658 |
| 94 | PIK3CA | 0.24531959 |
| 95 | ABL1 | 0.22881346 |
| 96 | AKT3 | 0.22149545 |
| 97 | IRAK2 | 0.21773506 |
| 98 | CAMK1G | 0.19897945 |
| 99 | PRKACB | 0.19677109 |
| 100 | MAPK3 | 0.19513836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.65196228 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45216123 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37126972 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33611970 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04234063 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.78533470 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73336472 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72989472 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64636491 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62645806 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51387232 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47998719 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24097147 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24071167 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.13717555 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06608169 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96732940 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91321114 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90750501 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90317765 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86527786 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85762977 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84101450 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81204332 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76195958 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71499158 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70021807 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66758259 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66216834 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64430894 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61279449 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53096081 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50485722 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49208346 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.48512876 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48193782 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44819320 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41680365 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38693814 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33368779 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28388731 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24302005 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22328635 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20105382 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.19423947 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17553672 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11683341 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11662158 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06036203 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04998377 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99621246 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95060763 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93152565 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92543589 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90042430 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88596556 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.85996120 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82926254 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78821792 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69256202 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69086044 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68755649 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61641405 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55497376 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51889625 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.48327150 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46464541 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45304482 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43568653 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30340188 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24161387 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23635881 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23160890 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22890415 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.21908392 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18928902 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15065213 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09846527 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01155694 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2480440 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2412146 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2162923 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2127318 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | -0.2121035 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2079903 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2012259 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1897778 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1677537 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1665982 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1601926 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1468141 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1458985 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1420413 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1336783 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1193774 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1181927 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0748896 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0728194 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0668604 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0141439 |

